Approvals/NMPA/Dapagliflozin and Metformin Hydrochloride Sustained-release Tablets (Ⅰ)

Approved

化学药品

Dapagliflozin and Metformin Hydrochloride Sustained-release Tablets (Ⅰ)

北京福元医药股份有限公司🇨🇳 National Medical Products Administration

Approval Id: 8h2mg3i5dxF
Approval Number: 国药准字H20253160
Generic Name: 达格列净二甲双胍缓释片(Ⅰ)
Generic Name En: Dapagliflozin and Metformin Hydrochloride Sustained-release Tablets (Ⅰ)
Drug Type: 化学药品
Dosage Form: 片剂
Strength: 达格列净10mg（以C₂₁H₂₅ClO₆计）和盐酸二甲双胍1000mg
Reg Date: 2025-01-14
Company Name: 北京福元医药股份有限公司
Company Address: 北京市通州区通州工业开发区广源东街8号
Production Company Name: 北京福元医药股份有限公司
Production Company Address: 北京市通州区通州工业开发区广源东街8号
Company Detail Path: /organization/bei-jing-fu-yuan-yi-yao-gu-fen-you-xian-gong-si
Production Company Detail Path: /organization/bei-jing-fu-yuan-yi-yao-gu-fen-you-xian-gong-si

Approved

Agency

NMPA

Country

🇨🇳

Approval Date

Jan 14, 2025

Approval ID

8h2mg3i5dxF

Type

化学药品